Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17508034rdf:typepubmed:Citationlld:pubmed
pubmed-article:17508034lifeskim:mentionsumls-concept:C0456909lld:lifeskim
pubmed-article:17508034lifeskim:mentionsumls-concept:C0035309lld:lifeskim
pubmed-article:17508034lifeskim:mentionsumls-concept:C0207071lld:lifeskim
pubmed-article:17508034lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:17508034lifeskim:mentionsumls-concept:C1522223lld:lifeskim
pubmed-article:17508034lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:17508034pubmed:issue3lld:pubmed
pubmed-article:17508034pubmed:dateCreated2007-5-17lld:pubmed
pubmed-article:17508034pubmed:abstractTextA recent phase I trial of an encapsulated cell therapy device that delivers ciliary neurotrophic factor has shown the potential of this approach in the treatment of retinitis pigmentosa. As experience with this device is gained, other retinal degenerative disorders may be potential targets of a similar therapeutic approach.lld:pubmed
pubmed-article:17508034pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508034pubmed:languageenglld:pubmed
pubmed-article:17508034pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508034pubmed:citationSubsetIMlld:pubmed
pubmed-article:17508034pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508034pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508034pubmed:statusMEDLINElld:pubmed
pubmed-article:17508034pubmed:monthJunlld:pubmed
pubmed-article:17508034pubmed:issn0008-4182lld:pubmed
pubmed-article:17508034pubmed:authorpubmed-author:SievingPaul...lld:pubmed
pubmed-article:17508034pubmed:authorpubmed-author:MacDonaldIan...lld:pubmed
pubmed-article:17508034pubmed:authorpubmed-author:SauvéYvesYlld:pubmed
pubmed-article:17508034pubmed:issnTypePrintlld:pubmed
pubmed-article:17508034pubmed:volume42lld:pubmed
pubmed-article:17508034pubmed:ownerNLMlld:pubmed
pubmed-article:17508034pubmed:authorsCompleteYlld:pubmed
pubmed-article:17508034pubmed:pagination399-402lld:pubmed
pubmed-article:17508034pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:meshHeadingpubmed-meshheading:17508034...lld:pubmed
pubmed-article:17508034pubmed:year2007lld:pubmed
pubmed-article:17508034pubmed:articleTitlePreventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants.lld:pubmed
pubmed-article:17508034pubmed:affiliationNational Eye Institute, National Institute of Health, Bethesda, MD 20892-1860, USA. macdonaldi@mail.nih.govlld:pubmed
pubmed-article:17508034pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17508034pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17508034pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
pubmed-article:17508034pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508034lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508034lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508034lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508034lld:pubmed